LIMN logo

Liminatus Pharma, Inc. (LIMN)

Profile

Full Name

Liminatus Pharma, Inc.

Ticker

NASDAQ: LIMN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 1, 2025

Indexes

Not included

Website

https://liminatuspharma.com

Employees

3

Key Details

Price

$0.72(-31.52%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.40(-163.92% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.72
    LIMN price is $0.72

    30-Day Relative Volume

    4.35
    LIMN 30-day relative volume is 4.35

    Price Performance

    Price Most Recent Change

    -31.52%
    LIMN price was down -31.52% on Nov 21, 2025

    Price YTD Change

    -
    LIMN price ytd change is unknown

    Price 1-Year Change

    -
    LIMN price 1-year change is unknown

    Price 3-Year Change

    -
    LIMN price 3-year change is unknown

    Price Range

    Price All-Time High

    $33.66
    LIMN price is currently -97.86% below its historical high of $33.66

    Price 3-Year Low

    $0.61
    LIMN price is currently +17.10% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $19.46M
    LIMN market cap is $19.46 million

    Market Cap 3-Year Change

    -
    LIMN market cap 3-year change is unknown

    Market Cap All-Time High

    $693.81M
    LIMN market cap is currently -97.20% below its historical high of $693.81 million

    Market Cap Sector Percentile

    23.49%
    LIMN market cap is higher than 23.49% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +279.11%
    LIMN shares outstanding is up +279.11% year-on-year

    Shares Outstanding 3-Year Change

    -1.94%
    LIMN shares outstanding is down -1.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.40
    LIMN beta is 1.40

    200-day SMA

    $5.46
    LIMN price is currently -86.84% below its 200-day simple moving average

    50-day SMA

    $1.36
    LIMN price is currently -47.27% below its 50-day simple moving average

    14-Day RSI

    23.14
    LIMN 14-day relative strength index is 23.14

    Volume

    4.35
    LIMN 30-day relative volume is 4.35

    ATR

    $0.17
    LIMN average true range is $0.17

    10-day Historical Volatility

    164.76%
    LIMN 10-day historical volatility is 164.76%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    LIMN annual revenue is $0.00

    Revenue Analysts Estimate

    -
    LIMN annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    LIMN annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.5%
    LIMN annual revenue is higher than 28.5% of companies in Healthcare sector

    EPS

    EPS

    -$0.40
    LIMN annual earnings per share is -$0.40

    EPS Analysts Estimate

    -
    LIMN annual earnings per share consensus analysts' forecast is unknown

    EPS 1-Year Change

    -163.92%
    LIMN annual earnings per share is down -163.92% year-on-year

    EPS Sector Percentile

    69.9%
    LIMN annual earnings per share is higher than 69.9% of companies in Healthcare sector

    Profit

    Gross Profit

    $0.00
    LIMN annual gross profit is $0.00

    Gross Margin

    -
    LIMN annual gross profit margin value is unknown

    Operating Profit

    -$2.91M
    LIMN annual operating income is -$2.91 million

    Operating Margin

    -
    LIMN annual operating profit margin value is unknown

    Net Income

    -$2.90M
    LIMN annual net profit is -$2.90 million

    Net Margin

    -
    LIMN annual net profit margin value is unknown

    Expenses

    Total Expenses

    $2.90M
    LIMN annual total expenses is $2.90 million

    Operating Expenses

    $2.91M
    LIMN annual total operating expenses is $2.91 million

    Cost Of Goods Sold

    $0.00
    LIMN annual cost of goods sold is $0.00

    Selling, General & Administrative Expenses

    $0.00
    LIMN annual SG&A is $0.00

    Depreciation & Amortization

    -
    LIMN annual D&A value is unknown

    Interest Expense

    $0.00
    LIMN annual interest expense is $0.00

    Income Tax

    $18.80K
    LIMN annual income tax is $18.80 thousand

    EBIT & EBITDA

    EBIT

    -$2.91M
    LIMN annual earnings before interest & taxes is -$2.91 million

    EBITDA

    -$2.91M
    LIMN annual EBITDA is -$2.91 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $2.83M
    LIMN annual total assets is $2.83 million

    Non Current Assets

    $2.02M
    LIMN annual long term assets is $2.02 million

    Current Assets

    $812.70K
    LIMN annual total current assets is $812.70 thousand

    Cash and Cash Equivalents

    $804.50K
    LIMN annual cash & cash equivalents is $804.50 thousand

    Accounts Receivable

    -
    LIMN annual accounts receivable value is unknown

    Inventory

    $0.00
    LIMN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $18.70M
    LIMN annual total liabilities is $18.70 million

    Long Term Liabilities

    $10.02M
    LIMN annual total long term liabilities is $10.02 million

    Current Liabilities

    $8.68M
    LIMN annual current liabilities is $8.68 million

    Accounts Payable

    $0.00
    LIMN annual accounts payable is $0.00

    Debt

    Total Debt

    $5.12M
    LIMN annual total debt is $5.12 million

    Total Debt 1-Year Change

    +125.56%
    LIMN annual total debt is up +125.56% year-on-year

    Long Term Debt

    $0.00
    LIMN annual long term debt is $0.00

    Short Term Debt

    $5.12M
    LIMN annual short term debt is $5.12 million

    Equity & Capital

    Shareholders Equity

    -$15.87M
    LIMN annual stockholders equity is -$15.87 million

    Book Value

    -$15.87M
    LIMN annual book value is -$15.87 million

    Retained Earnings

    -$17.52M
    LIMN annual retained earnings is -$17.52 million

    Working Capital

    -$7.87M
    LIMN annual working capital is -$7.87 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$3.11M
    LIMN annual cash from operations is -$3.11 million

    Cash From Operations 1-Year Change

    -48.69%
    LIMN annual cash from operations is down -48.69% year-on-year

    Cash From Investing

    $1.97M
    LIMN annual cash from investing is $1.97 million

    Cash From Investing 1-Year Change

    -82.72%
    LIMN annual cash from investing is down -82.72% year-on-year

    Cash From Financing

    $1.05M
    LIMN annual cash from financing is $1.05 million

    Cash From Financing 1-Year Change

    +111.11%
    LIMN annual cash from financing is up +111.11% year-on-year

    CAPEX

    CAPEX

    $0.00
    LIMN annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    LIMN annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$3.11M
    LIMN annual free cash flow is -$3.11 million

    Free Cash Flow 1-Year Change

    -48.69%
    LIMN annual free cash flow is down -48.69% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    LIMN annual gross profit margin value is unknown

    Operating Margin

    -
    LIMN annual operating profit margin value is unknown

    Net Margin

    -
    LIMN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -79.23%
    LIMN annual return on assets is -79.23%

    ROE

    18.30%
    LIMN annual return on equity is 18.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    LIMN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    LIMN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -11.82
    LIMN price to book ratio is -11.82

    PB Ratio Sector Percentile

    4.39%
    LIMN price to book ratio is higher than 4.39% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    LIMN price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    LIMN price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $20.18M
    LIMN enterprise value is $20.18 million

    Enterprise Value Sector Percentile

    27.61%
    LIMN enterprise value is higher than 27.61% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -8.62
    LIMN EV/EBITDA is -8.62

    EV/EBITDA Sector Percentile

    15.73%
    LIMN EV/EBITDA is higher than 15.73% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    0.09
    LIMN annual current ratio is 0.09

    Quick Ratio

    0.09
    LIMN annual quick ratio is 0.09

    Leverage

    Debt To Equity

    -0.32
    LIMN annual debt to equity ratio is -0.32

    Interest Coverage Ratio

    -
    LIMN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    LIMN piotroski f-score value is unknown

    Altman Z-Score

    -14.77
    LIMN altman z-score is -14.77

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with LIMN included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Liminatus Pharma, Inc.?
    • Does Liminatus Pharma, Inc. pay dividends?
    • What sector is Liminatus Pharma, Inc. in?
    • What industry is Liminatus Pharma, Inc. in?
    • What country is Liminatus Pharma, Inc. based in?
    • When did Liminatus Pharma, Inc. go public?
    • Is Liminatus Pharma, Inc. in the S&P 500?
    • Is Liminatus Pharma, Inc. in the NASDAQ 100?
    • Is Liminatus Pharma, Inc. in the Dow Jones?
    • When does Liminatus Pharma, Inc. report earnings?

    What is the ticker symbol for Liminatus Pharma, Inc.?

    The ticker symbol for Liminatus Pharma, Inc. is NASDAQ:LIMN

    Does Liminatus Pharma, Inc. pay dividends?

    No, Liminatus Pharma, Inc. does not pay dividends

    What sector is Liminatus Pharma, Inc. in?

    Liminatus Pharma, Inc. is in the Healthcare sector

    What industry is Liminatus Pharma, Inc. in?

    Liminatus Pharma, Inc. is in the Biotechnology industry

    What country is Liminatus Pharma, Inc. based in?

    Liminatus Pharma, Inc. is headquartered in United States

    When did Liminatus Pharma, Inc. go public?

    Liminatus Pharma, Inc.'s initial public offering (IPO) was on May 1, 2025

    Is Liminatus Pharma, Inc. in the S&P 500?

    No, Liminatus Pharma, Inc. is not included in the S&P 500 index

    Is Liminatus Pharma, Inc. in the NASDAQ 100?

    No, Liminatus Pharma, Inc. is not included in the NASDAQ 100 index

    Is Liminatus Pharma, Inc. in the Dow Jones?

    No, Liminatus Pharma, Inc. is not included in the Dow Jones index

    When does Liminatus Pharma, Inc. report earnings?

    The date for Liminatus Pharma, Inc.'s next earnings report has not been announced yet
    On this page